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It has been widely accepted that the early spliceosome assembly
begins with U1 small nuclear ribonucleoprotein (U1 snRNP) binding
to the 5′ splice site (5′SS), which is assisted by the Ser/Arg (SR)-rich
proteins in mammalian cells. In this process, the RS domain of SR
proteins is thought to directly interact with the RS motif of U1-70K,
which is subject to regulation by RS domain phosphorylation. Here
we report that the early spliceosome assembly event is mediated
by the RNA recognition domains (RRM) of serine/arginine-rich
splicing factor 1 (SRSF1), which bridges the RRM of U1-70K to
pre-mRNA by using the surface opposite to the RNA binding site.
Specific mutation in the RRMof SRSF1 that disrupted the RRM–RRM
interaction also inhibits the formation of spliceosomal E complex
and splicing. We further demonstrate that the hypo-phosphory-
lated RS domain of SRSF1 interacts with its own RRM, thus compet-
ing with U1-70K binding, whereas the hyper-phosphorylated RS
domain permits the formation of a ternary complex containing
ESE, an SR protein, and U1 snRNP. Therefore, phosphorylation of
the RS domain in SRSF1 appears to induce a key molecular switch
from intra- to intermolecular interactions, suggesting a plausible
mechanism for the documented requirement for the phosphoryla-
tion/dephosphorylation cycle during pre-mRNA splicing.
RNA splicing ∣ spliceosome complex ∣ exonic splicing enhancer ∣
protein phosphorylation
Pre-mRNA splicing is essential for gene expression by preciseremoval of intervening sequences known as introns. Because
splice site sequences are often insufficient to direct faithful recog-
nition of authentic splice sites, such a lack of sequence stringency
imposes a great challenge for the splicing machinery to assemble
on functional sites while avoiding numerous cryptic splice sites in
the pre-mRNA (1).
Regulatory elements, such as exonic splicing enhancer (ESE)
sequences, provide a key strategy to compensate for sequence
variations on authentic splice sites. ESE typically consists of
highly degenerate 6–8 nucleotide motifs (2, 3) that acts as positive
regulators for splice site selection, and many of them are speci-
fically recognized by SR proteins (3). ESE-bound SR proteins are
involved in the recruitment of snRNPs, although the precise
mechanisms of these recruitment events are only vaguely under-
stood (4–7). This process also plays a crucial role in splicing
regulation with the sequence elements, such as exonic and intro-
nic silencer sequences (ESS and ISS, respectively) act as negative
regulators by recruiting splicing repressors, such as heteroge-
neous nuclear RNPs (hnRNPs) (8, 9). The balance between these
opposing functional elements determines the overall splicing
strength in alternative splicing.
In addition to their well known activities in the regulation
of both constitutive and alternative splicing, SR proteins also
participate in postsplicing activities, such as mRNA nuclear
export, nonsense-mediated mRNA decay, and mRNA translation
(10, 11). SR proteins are characterized by having RNA recogni-
tion motifs (RRM) in the N terminus and Arg/Ser rich peptides
in a C-terminal domain, referred to as the RS domain. The SR
protein, SRSF1 (aka ASF/SF2), contains two RRMs and a rela-
tively short RS domain compared to other SR proteins. The C-
terminal RS domain of SRSF1 is phosphorylated by two protein
kinases to generate two distinct phosphorylation states. In the cy-
toplasm, SRSF1 is phosphorylated at approximately 12 serines
at the N-terminal portion of the RS domain by SRPK (12, 13).
This partially phosphorylated or hypo-phosphorylated SRSF1
(p-SRSF1) is then imported into the nucleus where it can be
further phosphorylated by the nuclear kinase CLK/STY to gen-
erate fully or hyper-phosphorylated SRSF1 (pp-SRSF1) (14).
Hyper-phosphorylation is thought to facilitate the recruitment
of SRSF1 to the active transcription and splicing sites (15).
Dephosphorylated SRSF1 is also linked to its postsplicing func-
tions (10, 11).
Phosphorylated SRSF1 has been shown to be crucial for U1
snRNP recruitment to the 5′SS (16, 17), which has long been
thought to be mediated by the interaction between the RS
domain of the SR protein and the RS-like domain present in
U1-70K, a specific component of U1 snRNP (7, 18). The RS
domain of SR and SR-like proteins has been shown to interact
at the branchpoint sites (BPS) during different stages of spliceo-
some assembly (19, 20). However, the precise mechanism of
SR protein-mediated spliceosome assemble is largely unknown.
In this study, we provide unique insights into biochemical
mechanisms of how SRSF1 prompts early spliceosome assembly
and phosphorylation regulation of this critical step. We show that
SRSF1 simultaneously recognizes an ESE and U1-70K to recruit
U1 snRNP to the 5′SS. However, contrary to the long-accepted
model for this early spliceosome assembly process, we discovered
that the interaction between SRSF1 and U1-70K is mediated by
their respective RNA recognition domains (RRMs). We further
show that the phosphorylation state of SRSF1 plays a modulatory
role in this tripartite interaction where the fully phosphorylated
RS domain allows ternary complex formation, but progressive
dephosphorylation of the RS domain switches the domain to
interact with its own RRM, thereby blocking the interaction of
SRSF1 with U1-70K. We further show that both the RRM-
mediated protein–protein interactions and the phosphorylation-
induced molecular switch are linked to spliceosomal E complex
formation and splicing.
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Results and Discussion
Reversible Phosphorylation of the RS Domain Modulates the Stability
of the ESE∶SRSF1 Complex. To understand the role of the RS
domain in ESE binding, we investigated how the RNA binding
domain that includes both RRMs (RRM1/2) in the N terminus
(Fig. 1A) binds ESE. We used a well-characterized ESE sequence
present within the exon of Ron (receptor tyrosine kinase). SRSF1
has been shown to be involved in alternative splicing by binding
to ESE (21–23). Filter binding (FB) assay revealed binding
saturation at a level of only approximately 40%, suggesting weak
stability of the Ron ESE∶SRSF1 (RRM1/2) complex (Fig. 1B).
The mutant Ron ESE (mRon) showed negligible binding
(Fig. 1C). These observations led us to conclude that SRSF1
(RRM1/2) binds to Ron ESE specifically but weakly.
To delineate the role of the RS domain in ESE binding, we
examined SRSF1 binding to Ron ESE using FB assay (Fig. 1B).
We determined that unphosphorylated SRSF1 bound Ron ESE
with a Kd of approximately 172 nM (Fig. 1 B and D). SRSF1
bound poorly to mRon indicating that SRSF1 binding to Ron
ESE was sequence-specific (Fig. 1C). We next used p-SRSF1
and pp-SRSF1, which were generated as previously described
(13) (Fig. 1A, bottom) to examine the binding affinity with the
same ESE. p-SRSF1 bound Ron ESE with high affinity compar-
able to that of unphosphorylated SRSF1 (Fig. 1 B and D). In
contrast, pp-SRSF1 showed a similar weak binding profile as
in SRSF1 (RRM1/2) (Fig. 1 B and D). Electrophoretic mobility
shift assay (EMSA) confirmed our conclusion from FB assay that
both SRSF1 and p-SRSF1 bound Ron ESE with high affinity
whereas both pp-SRSF1 and SRSF1 (RRM1/2) bound specifi-
cally but with low affinity (Fig. 2A and Fig. S1 A–C). Significantly
lower ESE binding affinity of fully phosphorylated SRSF1
relative to dephosphorylated or partially phosphorylated SRSF1
indicates phosphorylation-dependent alteration of ESE recogni-
tion by SRSF1.
Unphosphorylated RS Domain Stabilizes the ESE∶SRSF1 Complex
by Making Nonspecific Contacts with Both the RRMs and RNA. Our
study then focused on whether the high affinity of SRSF1 and
p-SRSF1 with ESE is induced by their unphosphorylated RS2
domain. For this, we evaluated ESE binding to SRSF1ΔRS2
and p-SRSF1ΔRS2 (Fig. S2A). The residual RS1 domain in
p-SRSF1ΔRS2 is fully phosphorylated. As shown in Fig. S2A,
SRSF1ΔRS2 and p-SRSF1ΔRS2 recapitulate binding by SRSF1
and pp-SRSF1, respectively, suggesting that the RS2 domain
played no specific role. It also suggests that the high affinity
of the SRSF1∶ESE complex results from both RRM-mediated
specific binding and charge-based binding by an unphosphory-
lated RS domain. Enhanced binding affinities of the ESE∶
SRSF1 and ESE∶p-SRSF1 complexes mediated by the unpho-
sphorylated RS domain might originate from different sources
by its direct contact with either RNA only, RRM1/2 only, or both
RNA and RRM1/2. To investigate these possibilities, we analyzed
the role of free RS domain both in its unphosphorylated and
phosphorylated forms. For this, two types of RS sequences,
GST-RS (197–248) and RS peptides were used. Both the fusion
protein and the RS peptide bound to ESE weakly in their unpho-
sphorylated state and no binding was observed when the RS
domain was phosphorylated (Fig. 2B and Fig. S2B). We next
examined whether free RS domains could also stabilize the
SRSF1 ðRRM1∕2Þ∶ESE complex. We found that GST-SRSF1
(RS) formed ternary complexes with SRSF1 (RRM1/2) and
ESE complex (Fig. 2C). No ternary complex was observed
with phosphorylated GST-SRSF1(RS) (GST-pp-RS) (Fig. S2 B
and C). A 16-mer RS dipeptide repeat peptide (RS16) behaved
nearly identically as the GST-RS domain. These results show
that the RS domain enhances the affinity of the complex by
fivefold [Kd of ESE∶RRM1∕2∶RS (approximately 300 nM) and
Fig. 1. Phosphorylation states of SRSF1 affect ESE binding affinity. (A) Car-
toon representation of SRSF1 domain organization (upper) and coomassie
stained SDS/PAGE showing unphosphorylated, hypo-phosphorylated (p-
SRSF1), and hyper-phosphorylated SRSF1 (pp-SRSF1). (B and C) Filter binding
assay showing the binding of SRSF1 (RRM1/2), SRSF1 (FL), p-SRSF1 (FL), and
pp-SRSF1 (FL) to Ron ESE (AGGCGGAGGAAGC) and to mut Ron ESE (mRon
ESE; AGGCGGUUGUUGC), respectively. The means and standard deviation
(SD) of the results from three independent experiments are shown. (D) Esti-
mated equilibrium dissociation constants (Kd ) of SRSF1∶ESE complexes were
measured based on FB assay (Rona) and EMSA (Ronb) (see Fig. S1A–C). Kd was
estimated as 50% of bound RNA fraction. ND denotes not determined. SD
was determined from three independent experiments.
Fig. 2. Unphosphorylated RS domain interacts with ESE∶SRSF1 (RRM1/2). (A)
EMSA showing the binding of SRSF1 (RRM1/2) to Ron ESE. (B) EMSA analysis
of ESE mixed with GST-RS (197–248) and GST-pp-RS (197–248). (C) EMSA
showing the binding of SRSF1 (RRM1/2) to GST-RS and GST-pp-RS. (D) GST
pull-down assay showing binding between His-SRSF1 (RRM1/2) (2 μg) and
GST-RS/GST-pp-RS (2 μg) in the absence or presence of Ron ESE or poly
U13. Input and bound proteins were detected by the Western blotting using
anti-His Ab. Bound fractions was quantitated from three independent experi-
ments (bottom). (E) The model depicting ESE binding to SRSF1 in its different
phosphorylated states.
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Kd of ESE∶RRM1∕2 (approximately 1;500 nM)]. However, as
the RS domain binds very weakly (Kd ∼ 1;250 nM), the RS-
RRM1/2 interaction must contribute to the stability of the ternary
complex.
To determine if the RS domain directly interacts with the
RRM1/2 as well as RNA-bound RRM1/2, we performed GST
pull-down assays (Fig. 2D). Our results revealed that the unpho-
sphorylated RS domain interacts with the RRM1/2, whereas
phosphorylated RS domain showed negligible binding. The
RRM1/2-RS interaction was enhanced in the presence of ESE
or poly-U RNA, indicating that RS binding to RNA∶RRM1∕2
complex is nonspecific, electrostatic in nature. The interactions
between RS and RRM1/2, and between RS and ESE suggest
that RNA-dependent enhancement of RRM1/2-RS interaction
is likely due to the tripartite contacts among ESE, RRM1/2,
and RS domain. Phosphorylated RS domain with negative charge
blocks the interactions with ESE and RRM1/2 (Fig. 2 B–D).
Altogether, these observations suggest an intriguing model where
the phosphorylation of the RS domain causes the dissociation
of the intramolecular interaction between the RS and RRM1/
2, and the “open” state of the RRM1/2 potentially interact with
other proteins during spliceosome assembly (Fig. 2E).
RRMs of SRSF1 Directly Interact with U1-70K RRM: Insights into U1
snRNP Recruitment to the 5′SS. The phosphorylation-dependent
switch of the intramolecular interaction between the RRM
and RS domain as described might be a critical regulatory step
in the spliceosome assembly, such as the recruitment of U1
snRNP to the 5′SS and its subsequent dissociation prior to U6
snRNA binding. Although it has been previously reported that
SRSF1 binds to U1-70K (7, 16, 17), we wanted to reexamine this
binding in light of our model. To examine the interactions
between SRSF1 and U1-70K under different states of phosphor-
ylation, we used un-, hypo-, and hyper-phosphorylated SRSF1
(Fig. S3A). However, phosphorylated SRSF1 bound directly and
indirectly to kinases (Fig. S3 B–D). To circumvent this problem,
we designed different phosphomimetic versions of SRSF1. To
generate unphosphorylated mimetic SRSF1 (RARA), all 18 ser-
ines in the RS domain were mutated to alanines. To mimic hypo-
and hyper-phosphorylation, all 12 serines in RS1 and all 18
serines in the entire RS domain were mutated to glutamic acids
to generate SRSF1 (RERA) and SRSF1 (RERE), respectively
(Fig. 3A). We performed GST pull-down experiments using these
GST-SRSF1 proteins and in vitro translated U1-70K (Fig. 3B).
We plotted the average amount of U1-70K retained from three
independent experiments (Fig. S3E).
We found both WT SRSF1 (FL) and SRSF1 (RARA) had no
interaction with in vitro translated U1-70K (FL) whereas both
SRSF1 (RERA) and SRSF1 (RERE) showed interaction. Con-
sistent with our model (Fig. 3C), the RS domain of wt SRSF1 and
the RARA domain of SRSF1 (RARA) are involved in intramo-
lecular interactions with its RRM1/2, thus preventing interactions
with U1-70K (FL). Such intramolecular interactions are absent in
SRSF1 (RRM1/2) and in SRSF1 (RERE), thereby permitting the
intermolecular interactions with U1-70K (FL). Interestingly,
SRSF1 (RERA) is able to interact with U1-70K (FL), demon-
strating that replacement of nearly two-third serines by glutamic
acids significantly weakened the intramolecular interactions, thus
allowing the intermolecular interactions between p-SRSF1 and
U1-70K. Using fragments of SRSF1 and U1-70K, we found that
both SRSF1 (RRM1/2) and SRSF1 (RS), which do not partici-
pate in intramolecular interaction, bound to U1-70K (FL) and
U1-70K (RRMs) (Fig. 3B). In addition, we observed that SRSF1
(RARA) interacts with U1-70K (RRMs) but not with U1-70K
(FL). This suggests that the RRM and the RS domain of U1-70K
(FL) may also participate mildly in an intramolecular interaction,
but the interaction between SRSF1 (RRMs) and U1-70K
(RRMs) is more predominant than U1-70K intramolecular inter-
action. Furthermore, the binding patterns remained the same in
the presence or absence of cognate RNA elements. Our overall
results by phosphomimetic mutants are consistent with the obser-
vation that U1-70K (FL) also interacts with p-SRSF1 and
pp-SRSF1 (Fig. S3A) in the presence of SRPK1 (Fig. S3B). In
all, these results suggest intricate and weak interactions exist
within and between SRSF1 and U1-70K that are sensitive to the
degree of SRSF1 phosphorylation as depicted (Fig. 3C). We next
carried out in vitro splicing assay using S100 complementation to
examine the impact of the intra- and intermolecular interactions
in U1-70K recognition by SRSF1 (Fig. 3D). We used WT SRSF1
and its phosphomimetic mutants (RARA, RERA, and RERE).
Unphosphorylated mimetic RARA mutant showed greatest
splicing defect and hypo-phosphorylated mimetic RERA was
partially defective. As observed previously by Cazalla et al. (24),
we also found that hyper-phosphorylated mimetic RERE mutant
supports splicing. These results demonstrate that disruption of
the intramolecular interactions in SRSF1 by phosphorylation
in the RS domain in turn permits the intermolecular interactions
with U1-70K, which is essential for splicing, despite the fact that
unphosphorylated SRSF1 binds to ESE with high affinity.
Disruption of the SRSF1∶U1-70K Complex Blocks Splicing. Further-
more, to investigate how the two RRMs of SRSF1 are involved
Fig. 3. U1-70K binding by SRSF1. (A) Schematic representation of domain
maps and fragments of U1-70K (left), phosphorylation mimetic versions of
SRSF1 (right), and sequences and phosphorylated sites of RS1 and RS2
domains (bottom). (B) GST pull-down assay between different GST-SRSF1
constructs (10 μg) and 5 μl of in vitro transcribed-translated [35S]-met labeled
U1-70K constructs in the presence of RNase A (upper) or in the presence of
cognate RNAs, Ron ESE and U1 snRNA (bottom). (C) Models depicting intra-
and intermolecular binding modes within and between SRSF1 and U1-70K.
(D) In vitro splicing of β-gb pre-mRNA in S100 complementation assay using
WT and different phosphorylation mimics of SRSF1 (FL). Relative splicing
efficiency of SRSF1 phosphomimetic mutants is shown in the bottom of
the gel.
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in direct interaction with U1-70K (RRM) in detail, we conducted
pull-down experiments with GST-SRSF1 (RRM1/2, RRM1, and
RRM2) and U1-70K (RRM) (Fig. 4A). We found that indeed the
two RRMs of SRSF1 and U1-70K bound each other under strin-
gent binding conditions (Fig. S4A). Further, the RRM1 domain,
which shows high homology with SRSF2, another U1-70K
binding protein, is responsible for binding to U1-70K (Fig. S4 B
and C). To understand the mechanism of how the RRMs of
SRSF1 recognizes U1-70K (RRM), we generated three different
mutants in RRM1 domain of SRSF1 guided by the structure of
SRSF1 RRM1 (PDB ID code 1X4A) (Fig. 4B). These mutants
are located on distinct patches opposite to the putative RNA
binding surface to determine if any of these patches is involved
in U1-70K binding (shown in yellow in Fig. 4B). We mutated
a pair of hydrophobic residues located on helix α1 to alanines
to create m1 (I32A/V35A). In addition, we altered the charged
surfaces by creating a pair of double mutants, m2 (K38A/Y39A)
and m3 (D66A/D69A) (Fig. 4B). All three mutants had similar
ESE binding affinities relative to WT SRSF1(RRM1/2), suggest-
ing that these mutations had no effect on RRMs folding and
were not involved in ESE binding (Fig. 4C). Two conserved
RNP1 phenylalanine residues in RRM1 have been shown to be
involved in ESE recognition (25) and as a control, we mutated
these residues to FF-DD (F56D/F58D), which showed negligible
RNA binding (Fig. 4C) as we expected.
Pull-down assays revealed that m1 was most defective in
U1-70K (RRM) binding (Fig. 4D). Thus, our results suggest that
the conserved hydrophobic patch on the SRSF1 surface, opposite
to the ESE binding surface, is at least partly responsible for
U1-70K recruitment. Further, to examine the effect of U1-70K
recruitment from defective SRSF1 mutants in splicing, SRSF1
mutants were generated both in the context of SRSF1 (FL)
and SRSF1 (RRM1/2). In vitro splicing assay with S100 comple-
mentation showed effective splicing activity in WT SRSF1 (FL),
m2 (FL), and m3 (FL), whereas m1 (FL) showed defective
splicing (Fig. 4E). Consistent with the splicing result of m1
(FL), m1 (RRM1/2) also showed the most pronounced splicing
defect (Fig. S4D). Whereas, m2 (RRM1/2) behaved similarly to
WT SRSF1 (RRM1/2) and m3 (RRM1/2) showed less splicing
defect. Although the interaction between U1-70K (RRM) and
m1 (RRM1/2) was only partially defective, this mutant showed
dramatic splicing defect. This observation can be explained by
two mutually exclusive arguments: First, we suggest that recruit-
ment of spliceosomal component to the specific substrates is
optimized through sensitive and weak interactions for splicing,
and even a minor defect in binding results in a major splicing
defect. Second, the same surface of SRSF1 may also be required
for a second recruitment event during the spliceosome assembly
such as the recruitment of U6 snRNP. Defect in multiple recruit-
ment events due to the surface mutation would amplify the defect
in overall enzymatic activity of the spliceosome. Altogether, our
results confirmed that U1-70K (RRM) and SRSF1 (RRM) inter-
act directly, and a conserved surface on RRM1 of SRSF1 bridges
ESE RNA and U1-70K.
Dephosphorylated SRSF1 and U1-70K Binding Defective SRSF1 (RRM)
Mutant Block Early Spliceosomal Assembly. Interaction between
U1-70K and SRSF1 is expected to facilitate U1 snRNP recruit-
ment to the 5′SS and subsequent formation of the E complex.
E complex is the first intermediate during the assembly of the
mature spliceosome (C complex) that can be visualized by native
gel electrophoresis. A and B complexes are two other subsequent
spliceosomal intermediates assembled in the splicing process. To
understand if the splicing defect of the dephosphorylated SRSF1
is affected by defective E complex formation, we tested SRSF1
phosphomimetic mutants (RARA, RERA, and RERE) for their
ability to form the E complex in S100 extract. We made a new
β-globin splicing template (β-gb (Ron)) by inserting the Ron ESE
in exon 2 (Fig. 5A). As shown in Fig. 5B, in the absence of SRSF1,
there was no E complex formation in S100 extract (Fig. 5B).
SRSF1 (RARA) also failed to support the E complex formation,
whereas the level of the E complex was reduced in the presence
of SRSF1 (RERA). As expected, SRSF1 (RERE) mutant sup-
ported the E complex formation. We further examined the for-
mation of later spliceosome complexes, A and B/C, in the
presence of ATP (Fig. 5C) by mutating the AG dinucleotides to
GG at the 3′SS junction (Fig. 5A). As expected, SRSF1 (RARA)
failed to form these complexes whereas SRSF1 (RERE) sup-
ported the spliceosome complexes to similar extent as the control
WT protein, SRSF1 (RSRS). Reduced levels of H complex in
the presence of RARAmutant is apparently due to the formation
of nonspecific aggregates, which failed to enter the gel. SRSF1
(RERA) also facilitated these later spliceosomal complexes
but to a lesser extent than that of SRSF1 (RERE) or WT protein.
tRNA challenge further showed that a significant fraction of the
complex was the unproductive H complex (compare left and right
panels in Fig. 5C. Behavior of these phosphorylated mimetic
mutants in spliceosome formation is correlated with their ability
to perform splicing of both WT β-gb and β-gb (Ron) substrates
(Figs. 3D and 5D).
Furthermore, we investigated if the spliceosomal intermediate
complex formation by WT and mutant SRSF1 (RRM1/2) also
correlates with their splicing activity. EMSA showed that SRSF1
(RRM1/2) WT, m2, and m3 induced the E complex formation,
whereas such complex was not observed in the case of m1
(Fig. 5E). As expected, m1 failed to support the formation of the
A and B/C complexes, whereas SRSF1 (RRM1/2) WT, m2, and
m3 formed the complexes (Fig. 5F). The most striking ob-
servation was the complete absence of spliceosomal complex
formation by m1, which is consistent with the splicing defect
observed in S100 complementation assay in both β-gb pre-mRNA
Fig. 4. Two opposite surfaces of SRSF1 (RRMs) recruit ESE and U1-70K (RRM).
(A) GST pull-down assay between GST-SRSF1 RRM1/2, RRM1, and RRM2 of
10 μg and U1-70K RRM (59–215) of 10 μg. (B) Ribbon presentation of SRSF1
(RRM1) (PDB ID code 1X4A). Putative RNA binding residues are denoted by
yellow color. Residues in each mutant m1 (I32A/V35A), m2 (K38A/Y39A), and
m3 (D68A/D69A) are denoted in three colors. (C) Ron ESE bindings to SRSF1
(RRM1/2)WT, m1, m2, m3, and FF-DDmutants (F56D/F58D) weremeasured by
filter binding assay with error bars (SD) from three independent experiments.
(D) Autoradiograph of GST pull-down assay between WT and mutants GST-
SRSF1 (RRM1/2), and in vitro translated [35S]-met labeled U1-70K (RRM). The
binding fraction of the U1-70K (RRM) toWTandmutants GST-SRSF1 (RRM1/2)
were quantitated from three independent experiments. (E) In vitro splicing
of β-gb pre-mRNA in S100 complementation assay using WT and mutants
SRSF1 (FL) and relative splicing efficiency is quantified as shown.
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substrates (Fig. 5G). Altogether, these results demonstrate that
fully dephosphorylated RS domain is functionally dominant and
that RRM alone can support splicing by promoting the assembly
of spliceosomal E complex. The suppression of splicing by the
unphosphorylated RS domain clearly implies the interplay of
the RRM and de/phosphorylated RS domain in the regulation
of spliceosome assembly and splicing.
Conclusion
Although numerous studies had characterized interactions be-
tween SRSF1 and U1-70K (7, 16, 17), the precise mechanism
of how they interact remains unclear. Detailed molecular dissec-
tion of protein–protein and protein–RNA interactions involving
SRSF1, U1-70K, and ESE with defined systems as presented in
our study reveals that SRSF1 bridges pre-mRNA to U1-70K
through their RRMs and that the RS domains play a modulatory
role (Fig. 6). The RS domain of SRSF1 acts as a phosphorylation-
dependent switch from intramolecular interaction to intermole-
cular interaction that then allows the binding of U1-70K. Upon
phosphorylation of the RS domain, the surface of SRSF1
(RRM1/2) that binds to its own RS domain becomes exposed
to U1-70K (RRM). Our study further supports the idea that
phosphorylation of SR proteins are absolutely essential for
splicing. It is still uncertain whether dephosphorylation is critical
during splicing because the SRSF1 (RERE), which cannot under-
go dephosphorylation, shows similar splicing activity as in WT.
However, a large number of recent reports clearly suggest invol-
vement of phosphatases for the second catalytic step to occur and
perhaps during other assembly steps or during disassembly of the
spliceosome after completion of the splicing reaction (7, 26–28).
We cannot eliminate the possibility that an unphosphorylated RS
domain from another SR protein or SR-related protein can com-
plement the defect of nondephosphorylatable mutant of SRSF1
by acting in trans. Dominant function of SRSF1 (RERE) in in
vitro splicing assay shown here and previously is consistent with
the observation that the hyper-phosphorylated SRSF1 mimetic
mutant rescued the cell death shown in SRSF1 knock-out mutant
in vivo (29).
Splice site recognition during the E complex formation re-
quires multiple protein–RNA and protein–protein recognition
events and a single RNA–RNA recognition event (30). Many of
these recognition processes are well characterized, such as RNA
binding with SRSF1, SF1, and U2AF; protein–protein contacts
among SF1-U2AF65, U2AF65-U2AF35, and SRSF1 (RRM1/2)-
U1-70K (RRM) (derived from this study); and finally, RNA–
RNA contacts between U1 snRNA and the 5′SS of the pre-
mRNA (Fig. 6). Stability of the E complex is the net result of
these relatively weak binary interactions. Enhancement of some
binary interaction strengths can negate the contribution of weak-
er interactions in the formation of the E complex. This is consis-
tent with the observation that SRSF1 (RRM1/2) alone can induce
splicing in S100 complementation assay from some but not all
pre-mRNA substrates (31). A strong correlation between the
strength of the 3′SS and the RS domain requirement in splicing
has also been reported (19, 20). We suggest that the strength of
the splice sites dictates the E complex formation pathway through
proper coupling of pre-mRNA and splicing factors and protein–
protein interactions among splicing factors at each splice site and
across the splice sites. In vitro assembly experiments with pure
components using different pre-mRNA substrates are necessary
to understand the underlying mechanism of how the splicing
activators couples to the splice site strengths.
Materials and Methods
To analyze the E complex formation, radiolabeled β-gb (Ron) pre-mRNA
was mixed with HeLa S100 extract and SR proteins as indicated under splicing
conditions in the absence of ATP and MgCl2 for 40 min at room temperature.
The products were resolved by 1.5% native agarose gel electrophoresis
as described (32). For analysis of ATP-dependent complexes, radiolabeled
β-gb (Ron)ΔAG pre-mRNA reaction mixtures (25 μl) were assembled in the
presence of ATP and MgCl2 under splicing condition for 40 min at 30 °C.
Then, 7 μl of the mixture were incubated with 0.5 mg∕mL heparin and
resolved by 2% native agarose gel for 4 h 30 min with 80 V in 0.5X TG buffer
at room temperature.
For additional details on gene cloning, in vitro transcription/translation,
protein purification, protein phosphorylation, EMSA, filter binding assay,
GST pull-down assay, and in vitro splicing assay, see SI Materials andMethods.
Fig. 5. Dephosphorylated RS domain and U1-70K binding defective mutant
of SRSF1 block early spliceosomal assembly steps. (A) Cartoon showing β-gb
(Ron) and β-gb (Ron)ΔAG constructs. (B) Native gel analysis of the spliceoso-
mal E complex formation by WT SRSF1 (RSRS) and different SRSF1 phospho-
mimetics in the presence of S100 extract and β-gb (Ron) pre-mRNA substrate.
(C) Native gel analysis of the spliceosomal A and B/C complex formation of
β-gb (Ron)ΔAG by SRSF1 phosphomimetics and WT (RSRS) without (left) or
with 0.1 mg∕mL tRNA (right) (D) In vitro splicing of the β-gb (Ron) pre-mRNA
substrate by SRSF1 phosphomimetics in the presence of S100 extract. The
relative splicing activities are shown at the bottom. (E) Native gel analysis
of the E complex formation by WT and mutant SRSF1 (RRM1/2) in S100
extract. (F) Native gel analysis of the spliceosomal A and B/C complex forma-
tion of β-gb (Ron)ΔAG by WT and SRSF1 (RRM1/2) mutants without (left) or
with 0.1 mg∕mL tRNA (right) in S100 extract. (G) In vitro splicing assay of β-gb
(Ron) pre-mRNA by WT and mutants SRSF1 (RRM1/2) in S100 extract. The
relative splicing activities of SRSF1 (RRM1/2) mutants compared to WT as
shown at bottom.
Fig. 6. A model depicting the effect of RS phosphorylation in the E complex
formation. Phosphorylation of the SRSF1 RS domain, mediated by the
sequential actions of SRPK1 and CLK/STY, induces the dissociation of the
RS from its RRM. Free SRSF1 (RRM) recruits U1 snRNP to the 5′SS through
RRM-RRM interaction between SRSF1 and U1-70K. Released pp-RS domain
interacts to the splicing factors bound to BPS/pY/3′SS to stabilize the E
complex.
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